Compare · CBLL vs FONR
CBLL vs FONR
Side-by-side comparison of CeriBell Inc. (CBLL) and Fonar Corporation (FONR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CBLL and FONR operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- CBLL carries a market cap of $1.08B.
- CBLL has hit the wire 8 times in the past 4 weeks while FONR has been quiet.
- CBLL has more recent analyst coverage (8 ratings vs 0 for FONR).
- Company
- CeriBell Inc.
- Fonar Corporation
- Price
- -
- -
- Market cap
- $1.08B
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2024
- 1981
- News (4w)
- 8
- 0
- Recent ratings
- 8
- 0
Fonar Corporation
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.
Latest CBLL
- Director Taylor Joseph Michael sold $277,644 worth of shares (10,200 units at $27.22), decreasing direct ownership by 21% to 38,278 units (SEC Form 4)
- Chief Technology Officer Woo Raymond exercised 4,887 shares at a strike of $3.65 and sold $131,754 worth of shares (4,887 units at $26.96) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 10-Q filed by CeriBell Inc.
- CeriBell Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Ceribell Reports Third Quarter 2026 Financial Results
- Ceribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium Monitoring Solution
- Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
- Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026
- Chief Technology Officer Woo Raymond exercised 4,887 shares at a strike of $3.65 and sold $119,145 worth of shares (4,887 units at $24.38) as part of a pre-agreed trading plan (SEC Form 4)
- Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis
Latest FONR
- Amendment: SEC Form SCHEDULE 13G/A filed by Fonar Corporation
- SEC Form 15-12G filed by Fonar Corporation
- SEC Form 4 filed by Director Chan Claudette
- New insider Chan Claudette claimed ownership of 106 units of FONAR CORPORATION COMMON STOCK (SEC Form 3)
- SEC Form 4 filed by Director Lehman Ronald G.
- Director Lehman Ronald G. was granted 4,330 units of FONAR CORPORATION COMMON STOCK (SEC Form 4)
- SEC Form 3 filed by new insider Lehman Ronald G.
- SEC Form 4 filed by Director Carrino Robert M.
- SEC Form 3 filed by new insider Carrino Robert M.
- SEC Form 4 filed by Director Maher Jessica